Supriya Lifescience shareholding pattern

·Pharma & HealthChart ›

Who owns itSep 2026 quarter

Promoters68.30%no change
Foreign investors (FII)6.44%+0.25 pts
Domestic institutions (DII)5.47%+0.17 pts
of which mutual funds1.28%−0.01 pts
of which insurance companies2.37%
Public19.79%

Per cent of all shares; change on the Jun 2026 quarter, in percentage points. As filed with the exchanges.

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

SUPRIYA₹869.30

Supriya Lifescience Ltd.

· Pharma & Health
₹ CrorePeersSTARSPARCTHYROCARESHILPAMEDVIYASHRUBICONYATHARTHPARKHOSPS
Holding % of Total Shares
12 Months Ending
Q1 FY25
30/06/2024
Q2 FY25
30/09/2024
Q3 FY25
31/12/2024
Q4 FY25
31/03/2025
Q1 FY26
30/06/2025
Q2 FY26
30/09/2025
Q3 FY26
31/12/2025
Q4 FY26
31/03/2026
Q1 FY27
30/06/2026
Q2 FY27
30/09/2026
Promoter & Group68.3068.3068.3068.3068.3068.3068.3068.3068.3068.30
FII / FPI4.956.036.527.196.785.465.205.166.196.44
DII5.485.454.924.264.865.225.015.705.305.47
Mutual Funds0.130.620.670.660.680.680.671.331.291.28
Latest: 2026-09-30 · 21 quarters of history · click a row to chart it.
« ‹ › »Latest: FY25 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 89%.